Caitlin Laura Montgomery, MD
Pediatrics · Santa Clara
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- California licence: Delinquent
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Montgomery’s office at (408) 524-5952 to ask if they take your plan before you enroll.
California Medical Board record
Licence A146233 · Delinquent
Licence status: Delinquent · since 2016 · expires 2022-09-30 · University of Missouri-Kansas City School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$50,376 in 2024
Medicaid paid $50,376 for 702 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 177 | $20,091 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 123 | $13,916 |
| Short return visit (20+ min) | 100 | $9,108 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 26 | $3,233 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 66 | $1,826 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 110 | $1,150 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 67 | $701 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 33 | $350 |
| 2024 | 702 | 8 | 26 | $50,376 |
| 2023 | 367 | 8 | 55 | $28,813 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 87 | $8,029 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 66 | $7,680 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 41 | $4,749 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 37 | $4,343 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 19 | $2,236 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 88 | $872 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 16 | $600 |
| Application of topical fluoride | 13 | $304 |
Money from drug and device companies
$300 in 2025
| 2025 | 8 | 15 | None | $300 |
| 2024 | 10 | 19 | None | $369 |
| 2023 | 4 | 6 | None | $114 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Cranial Technologies | Doc Band | $85 | 4 payments
|
| Collegium Pharmaceutical | Jornay Pm | $54 | 3 payments
|
| Tris Pharma | Dyanavel Xr | $35 | 2 payments
|
| GlaxoSmithKline | Bexsero | $34 | 2 payments
|
| Sanofi-Aventis U.S. | Tzield | $33 | 1 payment
|
| Abbvie | Lupron Depot | $24 | 1 payment
|
See all 15 published payments
| Cranial Technologies | Meals · 2025-10-24 | Doc Band | $17 |
| Neurelis | Meals · 2025-09-12 | Valtoco | $15 |
| Collegium Pharmaceutical | Meals · 2025-09-05 | Jornay Pm | $15 |
| Tris Pharma | Meals · 2025-08-25 | Dyanavel Xr | $19 |
| Collegium Pharmaceutical | Meals · 2025-08-08 | Jornay Pm | $20 |
| GlaxoSmithKline | Meals · 2025-07-11 | Bexsero | $16 |
| Cranial Technologies | Meals · 2025-05-16 | Doc Band | $22 |
| Sanofi-Aventis U.S. | Meals · 2025-05-12 | Tzield | $33 |
| Pfizer | Meals · 2025-04-07 | Prevnar 20 | $20 |
| Collegium Pharmaceutical | Meals · 2025-03-28 | Jornay Pm | $19 |
| Cranial Technologies | Meals · 2025-02-28 | Doc Band | $19 |
| Tris Pharma | Meals · 2025-02-14 | Onyda Xr | $15 |
| Abbvie | Meals · 2025-02-04 | Lupron Depot | $24 |
| GlaxoSmithKline | Meals · 2025-01-31 | Bexsero | $18 |
| Cranial Technologies | Meals · 2025-01-24 | Doc Band | $27 |
See earlier years (2024, 2023)
2024: $369
| Corium | Azstarys | $65 | 3 payments
|
| Ironshore Pharmaceuticals | Jornay Pm | $55 | 3 payments
|
| Cranial Technologies | Doc Band | $47 | 3 payments
|
| Ironwood Pharmaceuticals | Linzess | $41 | 2 payments
|
| Pfizer | Prevnar 20 | $40 | 2 payments
|
| GlaxoSmithKline | Bexsero | $35 | 2 payments
|
| Kyowa Kirin | Crysvita | $26 | 1 payment
|
| Sanofi Pasteur | Vaxelis | $24 | 1 payment
|
| Abbvie | Lupron Depot | $22 | 1 payment
|
| Merck Sharp & Dohme | Gardasil | $14 | 1 payment
|
2023: $114
| Ironshore Pharmaceuticals | Jornay Pm | $41 | 2 payments
|
| Cranial Technologies | Doc Band | $35 | 2 payments
|
| GlaxoSmithKline | Bexsero | $21 | 1 payment
|
| Pfizer | Trumenba | $16 | 1 payment
|
Professional record
- NPI
- 1336534775
- Licence
- CA A146233California A146233: Delinquent · expires 2022-09-30
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X); Student in a training program (390200000X)
- Mailing address
- 2350 W El Camino Real Fl 2, Mountain View, CA, 94040
- NPI first listed
- 2015-04-02
- NPI last updated
- 2018-08-10
This is when the NPI record was last certified, not a medical board exam.